APA (7th ed.) Citation

LS, L., LM, B., W, G., R, V., RW, P., OC, M., & SN, C. (2020). Ondansetron use in the first trimester of pregnancy and the risk of neonatal ventricular septal defect. International journal of epidemiology, 49(2), 648. https://doi.org/10.1093/ije/dyz255

Chicago Style (17th ed.) Citation

LS, Lemon, Bodnar LM, Garrard W, Venkataramanan R, Platt RW, Marroquin OC, and Caritis SN. "Ondansetron Use in the First Trimester of Pregnancy and the Risk of Neonatal Ventricular Septal Defect." International Journal of Epidemiology 49, no. 2 (2020): 648. https://doi.org/10.1093/ije/dyz255.

MLA (9th ed.) Citation

LS, Lemon, et al. "Ondansetron Use in the First Trimester of Pregnancy and the Risk of Neonatal Ventricular Septal Defect." International Journal of Epidemiology, vol. 49, no. 2, 2020, p. 648, https://doi.org/10.1093/ije/dyz255.